These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27160047)

  • 1. Application value of diffusion weighted whole body imaging with background body signal suppression in monitoring the response to treatment of bone marrow involvement in lymphoma.
    Sun M; Cheng J; Zhang Y; Wang F; Meng Y; Fu X
    J Magn Reson Imaging; 2016 Dec; 44(6):1522-1529. PubMed ID: 27160047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.
    Bonaffini PA; Ippolito D; Casiraghi A; Besostri V; Franzesi CT; Sironi S
    Acad Radiol; 2015 Sep; 22(9):1163-71. PubMed ID: 26182979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of dual-source parallel RF excitation for diffusion-weighted whole-body MR imaging with background body signal suppression at 3.0 T.
    Mürtz P; Kaschner M; Träber F; Kukuk GM; Büdenbender SM; Skowasch D; Gieseke J; Schild HH; Willinek WA
    Eur J Radiol; 2012 Nov; 81(11):3614-23. PubMed ID: 22178311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas.
    Stéphane V; Samuel B; Vincent D; Joelle G; Remy P; Francois GG; Jean-Pierre T
    Eur J Radiol; 2013 Nov; 82(11):2011-7. PubMed ID: 23932096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of diffusion-weighted (DW) MRI with background signal suppression (MR-DWIBS) in diagnosis of mediastinal lymph node metastasis of nonsmall-cell lung cancer (NSCLC).
    Xu L; Tian J; Liu Y; Li C
    J Magn Reson Imaging; 2014 Jul; 40(1):200-5. PubMed ID: 24923480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body MRI-DWI for assessment of residual disease after completion of therapy in lymphoma: A prospective multicenter study.
    Littooij AS; Kwee TC; de Keizer B; Bruin MC; Coma A; Beek FJ; Fijnheer R; Nievelstein RA
    J Magn Reson Imaging; 2015 Dec; 42(6):1646-55. PubMed ID: 25952024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD.
    Albano D; Patti C; Matranga D; Lagalla R; Midiri M; Galia M
    Eur J Radiol; 2018 Jun; 103():90-98. PubMed ID: 29803392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of DWIBS in malignant lymphoma: correlation between ADC values and Ki-67 index.
    Sun M; Cheng J; Zhang Y; Bai J; Wang F; Meng Y; Li Z
    Eur Radiol; 2018 Apr; 28(4):1701-1708. PubMed ID: 29143105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
    Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very early indicators of response to systemic therapy in lymphoma patients based on alterations in water diffusivity--a preliminary experience in 20 patients undergoing whole-body diffusion-weighted imaging.
    Horger M; Claussen C; Kramer U; Fenchel M; Lichy M; Kaufmann S
    Eur J Radiol; 2014 Sep; 83(9):1655-64. PubMed ID: 24972451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy.
    Onal C; Erbay G; Guler OC
    J Magn Reson Imaging; 2016 Oct; 44(4):1010-9. PubMed ID: 26919800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between the minimum and mean apparent diffusion coefficient values of hepatocellular carcinoma and tumor grade.
    Li X; Zhang K; Shi Y; Wang F; Meng X
    J Magn Reson Imaging; 2016 Dec; 44(6):1442-1447. PubMed ID: 27228086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-weighted imaging in the head and neck region: usefulness of apparent diffusion coefficient values for characterization of lesions.
    Şerifoğlu İ; Oz İİ; Damar M; Tokgöz Ö; Yazgan Ö; Erdem Z
    Diagn Interv Radiol; 2015; 21(3):208-14. PubMed ID: 25910284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results.
    Horger M; Weisel K; Horger W; Mroue A; Fenchel M; Lichy M
    AJR Am J Roentgenol; 2011 Jun; 196(6):W790-5. PubMed ID: 21606271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging of focal vertebral bone marrow lesions: initial experience of the differentiation of nodular hyperplastic hematopoietic bone marrow from malignant lesions.
    Park S; Kwack KS; Chung NS; Hwang J; Lee HY; Kim JH
    Skeletal Radiol; 2017 May; 46(5):675-683. PubMed ID: 28265697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
    Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of naive indolent lymphoma using whole-body diffusion-weighted imaging and T2-weighted MRI: results of a prospective study in 30 patients.
    Hong GS; Chae EJ; Ryu JS; Chae SY; Lee HS; Yoon DH; Suh C
    Cancer Imaging; 2021 Jan; 21(1):5. PubMed ID: 33413685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted MR imaging with background body signal suppression (DWIBS) for the diagnosis of malignant and benign breast lesions.
    Stadlbauer A; Bernt R; Gruber S; Bogner W; Pinker K; van der Riet W; Haller J; Salomonowitz E
    Eur Radiol; 2009 Oct; 19(10):2349-56. PubMed ID: 19415286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
    Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
    J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI.
    Liu C; Liang C; Liu Z; Zhang S; Huang B
    Eur J Radiol; 2013 Dec; 82(12):e782-9. PubMed ID: 24034833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.